Table of Contents
Ulcers
Volume 2011 (2011), Article ID 714046, 8 pages
http://dx.doi.org/10.1155/2011/714046
Review Article

Chronic Inflammation and Malignancy in Ulcerative Colitis

1Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Rush University, Chicago, IL 60612, USA
2Section of Gastroenterology and Nutrition, Rush University Medical Center, 1745 West Harrison Street, Professional Building, Suite 206, Chicago, IL 60612, USA

Received 12 December 2010; Accepted 1 February 2011

Academic Editor: T. Arakawa

Copyright © 2011 Sai Sunkara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Podolsky, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 347, no. 6, pp. 417–429, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. A. Eaden, K. R. Abrams, and J. F. Mayberry, “The risk of colorectal cancer in ulcerative colitis: a meta-analysis,” Gut, vol. 48, no. 4, pp. 526–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Itzkowitz and X. Yio, “Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation,” American Journal of Physiology, vol. 287, no. 1, pp. G7–G17, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. Mathy, K. Schneider, Y. Y. Chen, M. Varma, J. P. Terdiman, and U. Mahadevan, “Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 9, no. 6, pp. 351–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. N. Kulaylat and M. T. Dayton, “Ulcerative colitis and cancer,” Journal of Surgical Oncology, vol. 101, no. 8, pp. 706–712, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. H. Riddell, H. Goldman, and D. F. Ransohoff, “Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications,” Human Pathology, vol. 14, no. 11, pp. 931–966, 1983. View at Google Scholar · View at Scopus
  7. A. Von Herbay, C. Herfarth, and H. F. Otto, “Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen,” Zeitschrift für Gastroenterologie, vol. 32, no. 7, pp. 382–388, 1994. View at Google Scholar · View at Scopus
  8. J. Potack and S. H. Itzkowitz, “Colorectal cancer in inflammatory bowel disease,” Gut and Liver, pp. 61–73, 2008. View at Google Scholar
  9. V. J. Croog, T. A. Ullman, and S. H. Itzkowitz, “Chemoprevention of colorectal cancer in ulcerative colitis,” International Journal of Colorectal Disease, vol. 18, no. 5, pp. 392–400, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. B. Crohn and H. Rosenberg, “The sigmoidoscopic picture of chronic ulcerative colitis (non-specific),” The American Journal of the Medical Sciences, vol. 170, pp. 220–228, 1925. View at Google Scholar
  11. D. Palli, G. Trallori, S. Bagnoli et al., “Hodgkin's disease risk is increased in patients with ulcerative colitis,” Gastroenterology, vol. 119, no. 3, pp. 647–653, 2000. View at Google Scholar · View at Scopus
  12. C. N. Bernstein, J. F. Blanchard, E. Kliewer, and A. Wajda, “Cancer risk in patients with inflammatory bowel disease: a population-based study,” Cancer, vol. 91, no. 4, pp. 854–862, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. V. Winther, T. Jess, E. Langholz, P. Munkholm, and V. Binder, “Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County,” Gastroenterology, vol. 125, no. 6, pp. 1576–1582, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Kewenter, H. Ahlman, and L. Hultén, “Cancer risk in extensive ulcerative colitis,” Annals of Surgery, vol. 188, no. 6, pp. 824–828, 1978. View at Google Scholar · View at Scopus
  15. S. N. Gyde, P. Prior, R. N. Allan et al., “Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres,” Gut, vol. 29, no. 2, pp. 206–217, 1988. View at Google Scholar
  16. U. Broomé and A. Bergquist, “Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer,” Seminars in Liver Disease, vol. 26, no. 1, pp. 31–41, 2006. View at Google Scholar
  17. E. Langholz, P. Munkholm, M. Davidsen, and V. Binder, “Course of ulcerative colitis: analysis of changes in disease activity over years,” Gastroenterology, vol. 107, no. 1, pp. 3–11, 1994. View at Google Scholar
  18. C. J. Karvellas, R. N. Fedorak, J. Hanson, and C. K. W. Wong, “Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age,” Canadian Journal of Gastroenterology, vol. 21, no. 7, pp. 443–446, 2007. View at Google Scholar
  19. A. Sugita, D. B. Sachar, C. Bodian, M. B. Ribeiro, A. H. Aufses, and A. J. Greenstein, “Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval,” Gut, vol. 32, no. 2, pp. 167–169, 1991. View at Google Scholar
  20. A. Ekbom, C. Helmick, M. Zack, and H. O. Adami, “Ulcerative colitis and colorectal cancer: a population-based study,” The New England Journal of Medicine, vol. 323, no. 18, pp. 1228–1233, 1990. View at Google Scholar
  21. U. A. Heuschen, U. Hinz, E. H. Allemeyer et al., “Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis,” Gastroenterology, vol. 120, no. 4, pp. 841–847, 2001. View at Google Scholar
  22. J. P. J. Issa, N. Ahuja, M. Toyota, M. P. Bronner, and T. A. Brentnall, “Accelerated age-related CpG island methylation in ulcerative colitis,” Cancer Research, vol. 61, no. 9, pp. 3573–3577, 2001. View at Google Scholar · View at Scopus
  23. S. Itzkowitz, “Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice,” Journal of Clinical Gastroenterology, vol. 36, no. 5, pp. S70–S74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. P. Hussain, P. Amstad, K. Raja et al., “Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease,” Cancer Research, vol. 60, no. 13, pp. 3333–3337, 2000. View at Google Scholar · View at Scopus
  25. S. H. Itzkowitz, “Molecular biology of dysplasia and cancer in inflammatory bowel disease,” Gastroenterology Clinics of North America, vol. 35, no. 3, pp. 553–571, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. O. Blackstone, R. H. Riddell, B. H. G. Rodgers, and B. Levin, “Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy,” Gastroenterology, vol. 80, no. 2, pp. 366–374, 1981. View at Google Scholar · View at Scopus
  27. C. N. Bernstein, F. Shanahan, and W. M. Weinstein, “Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?” The Lancet, vol. 343, no. 8889, pp. 71–74, 1994. View at Publisher · View at Google Scholar
  28. R. D. Odze, F. A. Farraye, J. L. Hecht, and J. L. Hornick, “Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis,” Clinical Gastroenterology and Hepatology, vol. 2, no. 7, pp. 534–541, 2004. View at Publisher · View at Google Scholar
  29. J. B. J. Fozard and M. F. Dixon, “Colonoscopic surveillance in ulcerative colitis—dysplasia through the looking glass,” Gut, vol. 30, no. 3, pp. 285–292, 1989. View at Google Scholar
  30. J. Onkin, “Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?” Inflammatory Bowel Disease, vol. 14, pp. 196–197, 2008. View at Google Scholar
  31. T. Byers, B. Levin, D. Rothenberger, G. D. Dodd, and R. A. Smith, “American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997,” Ca: A Cancer Journal for Clinicians, vol. 47, no. 3, pp. 154–160, 1997. View at Google Scholar
  32. S. H. Itzkowitz, D. H. Present, V. Binder et al., “Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 11, no. 3, pp. 314–321, 2005. View at Publisher · View at Google Scholar
  33. R. C. Thomas, C. Selinger, and M. D. Rutter, “Adherence to BSG adenoma surveillance guidelines will reduce colonoscopic workload,” Gut, vol. 54, no. 1, p. 173, 2005. View at Google Scholar
  34. T. L. Zisman and D. T. Rubin, “Colorectal cancer and dysplasia in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 14, no. 17, pp. 2662–2669, 2008. View at Publisher · View at Google Scholar
  35. D. A. F. Lynch, A. J. Lobo, G. M. Sobala, M. F. Dixon, and A. T. R. Axon, “Failure of colonoscopic surveillance in ulcerative colitis,” Gut, vol. 34, no. 8, pp. 1075–1080, 1993. View at Google Scholar
  36. M. J. Carter, A. J. Lobo, and S. P. L. Travis, “Guidelines for the management of inflammatory bowel disease in adults,” Gut, vol. 53, no. 5, pp. v1–v16, 2004. View at Publisher · View at Google Scholar · View at PubMed
  37. A. Kornbluth and D. B. Sachar, “Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee,” American Journal of Gastroenterology, vol. 99, no. 7, pp. 1371–1385, 2004. View at Publisher · View at Google Scholar · View at PubMed
  38. T. Ullman, R. Odze, and F. A. Farraye, “Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon,” Inflammatory Bowel Diseases, vol. 15, no. 4, pp. 630–638, 2009. View at Publisher · View at Google Scholar · View at PubMed
  39. P. D. Collins, C. Mpofu, A. J. Watson, and J. M. Rhodes, “Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD000279, 2006. View at Google Scholar
  40. G. N. J. Tytgat, V. Dhir, and N. Gopinath, “Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease,” European Journal of Cancer Part A, vol. 31, no. 7-8, pp. 1174–1177, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Rutter, C. Bernstein, T. Matsumoto, R. Kiesslich, and M. Neurath, “Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining,” Endoscopy, vol. 36, no. 12, pp. 1109–1114, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. Kiesslich, J. Fritsch, M. Holtmann et al., “Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis,” Gastroenterology, vol. 124, no. 4, pp. 880–888, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S. E. Kudo, S. Tamura, T. Nakajima, H. O. Yamano, H. Kusaka, and H. Watanabe, “Diagnosis of colorectal tumorous lesions by magnifying endoscopy,” Gastrointestinal Endoscopy, vol. 44, no. 1, pp. 8–14, 1996. View at Google Scholar · View at Scopus
  44. S. Winawer, R. Fletcher, D. Rex et al., “Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence,” Gastroenterology, vol. 124, no. 2, pp. 544–560, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. P. Hurlstone, D. S. Sanders, A. J. Lobo, M. E. McAlindon, and S. S. Cross, “Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation,” Endoscopy, vol. 37, no. 12, pp. 1186–1192, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. E. East, N. Suzuki, A. Von Herbay, and B. P. Saunders, “Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses,” Gut, vol. 55, no. 10, pp. 1432–1435, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. E. Dekker, F. J. C. van den Broek, J. B. Reitsma et al., “Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis,” Endoscopy, vol. 39, no. 3, pp. 216–221, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. K. Kuznetsov, R. Lambert, and J. F. Rey, “Narrow-band imaging: potential and limitations,” Endoscopy, vol. 38, no. 1, pp. 76–81, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. M. Goetz, A. Hoffman, P. R. Galle, M. F. Neurath, and R. Kiesslich, “Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach,” Future Oncology, vol. 2, no. 4, pp. 469–476, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. R. Kiesslich, M. Goetz, K. Lammersdorf et al., “Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis,” Gastroenterology, vol. 132, no. 3, pp. 874–882, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. S. R. Ritland, J. A. Leighton, R. E. Hirsch, J. D. Morrow, A. L. Weaver, and S. J. Gendler, “Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse,” Clinical Cancer Research, vol. 5, no. 4, pp. 855–863, 1999. View at Google Scholar · View at Scopus
  52. R. N. DuBois, F. M. Giardiello, and W. E. Smalley, “Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention,” Gastroenterology Clinics of North America, vol. 25, no. 4, pp. 773–791, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Bansal and A. Sonnenberg, “Risk factors of colorectal cancer in inflammatory bowel disease,” American Journal of Gastroenterology, vol. 91, no. 1, pp. 44–48, 1996. View at Google Scholar · View at Scopus
  54. A. Farhadi, S. Gundlapalli, M. Shaikh et al., “Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis,” Liver International, vol. 28, no. 7, pp. 1026–1033, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. N. M. Davies, “Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine,” Diseases of the Colon and Rectum, vol. 38, no. 12, pp. 1311–1321, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Eaden, “Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 18, no. 2, pp. 15–21, 2003. View at Google Scholar · View at Scopus
  57. S. N. Agoff, T. A. Brentnall, D. A. Crispin et al., “The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia,” American Journal of Pathology, vol. 157, no. 3, pp. 737–745, 2000. View at Google Scholar
  58. D. S. Pardi, E. V. Loftus, W. K. Kremers, J. Keach, and K. D. Lindor, “Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis,” Gastroenterology, vol. 124, no. 4, pp. 889–893, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. I. A. Mouzas, E. Papavassiliou, and I. Koutroubakis, “Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate,” Italian Journal of Gastroenterology and Hepatology, vol. 30, no. 4, pp. 421–425, 1998. View at Google Scholar · View at Scopus
  60. J. Carrier, A. Medline, K. J. Sohn et al., “Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and β-microglobulin-deficient mice,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 11, pp. 1262–1267, 2003. View at Google Scholar · View at Scopus
  61. B. A. Lashner, P. A. Heidenreich, G. L. Su, S. V. Kane, and S. B. Hanauer, “Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study,” Gastroenterology, vol. 97, no. 2, pp. 255–259, 1989. View at Google Scholar · View at Scopus
  62. B. A. Lashner, K. S. Provencher, D. L. Seidner, A. Knesebeck, and A. Brzezinski, “The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis,” Gastroenterology, vol. 112, no. 1, pp. 29–32, 1997. View at Google Scholar · View at Scopus
  63. S. Matula, V. Croog, S. Itzkowitz et al., “Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine,” Clinical Gastroenterology and Hepatology, vol. 3, no. 10, pp. 1015–1021, 2005. View at Publisher · View at Google Scholar · View at Scopus